Promoter methylation of cancer-related genes in gastric carcinoma

Experimental Oncology

Volumn 30, Issue 2, 2008, Pages 112-116

  Poplawski, T ^a   Tomaszewska, K ^a   Galicki, M ^b   Morawiec, Z ^b   Blasiak, J ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b N Copernicus Hospital   (Poland)

Author keywords

Cancer related genes; DNA hypermethylation; Gastric cancer; MSRE PCR

Indexed keywords

ADULT; AGED; APAF GENE; ARTICLE; CANCER PATIENT; CARCINOGENESIS; CASP 8 GENE; CDH1 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA METHYLATION; EPIGENETICS; FAMILY HISTORY; FAS GENE; FEMALE; GENDER; GENE; GENETIC ASSOCIATION; GSTP1 GENE; HMLH1 GENE; HUMAN; HUMAN TISSUE; MALE; METHYLATION SPECIFIC RESTRICTION ENZYME DIGESTION; ONCOGENE; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PROMOTER REGION; RISK FACTOR; SMOKING; STOMACH CARCINOMA; STOMACH TUMOR; TECHNIQUE; TUMOR BIOPSY; TUMOR GENE;

CARCINOMA; DNA; DNA METHYLATION; DNA PRIMERS; FEMALE; GENE SILENCING; HUMANS; MALE; METHYLATION; MODELS, BIOLOGICAL; MODELS, STATISTICAL; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS;

EID: 46749128980     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Baylin SB, Herman JG, Graff JR, et al. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998; 72: 141-96.
2. Santos-Reboucas CB, Pimentel MM. Implication of abnormal epigenetic patterns for human diseases. Eur J Hum Genet 2007; 15: 10-7.
3. Suzuki FH. Distinct methylation pattern and microsatellite instability in sporadic gastric cancer. Int J Cancer 1999; 83: 309-13.
4. Leal MF, Lima EM, Silva PN, et al. Promoter hyper-methylation of CDH1, FHIT, MTAP and PLAGL1 in gastric adenocarcinoma in individuals from Northern Brazil. World J Gastroenterol 2007; 13: 2568-74.
5. Leung SY, Yuen ST, Chung LP, et al. hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res 1999; 59: 159-64.
6. Gronbaek K, Hother C, Jones PA. Epigenetic changes in cancer. Apmis 2007; 115: 1039-59.
7. Ekert PG, Read SH, Silke J, et al. Apaf-1 and cas-pase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die. J Cell Biol 2004; 165: 835-42.
8. Marsden VS, O'Connor L, O'Reilly LA, et al. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature 2002; 419: 634-7.
9. Ho CK, Bush JA, Li G. Tissue-specific regulation of Apaf-1 expression by p53. Oncol Rep 2003; 10: 1139-43.
10. Leo C, Richter C, Horn LC, et al. Expression of Apaf-1 in cervical cancer correlates with lymph node metastasis but not with intratumoral hypoxia. Gynecol Oncol 2005; 97: 602-6.
11. Anichini A, Mortarini R, Sensi M, et al. APAF-1 signaling in human melanoma. Cancer Lett 2006; 238: 168-79.
12. Rouvier E, Luciani MF, Golstein P. Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J Exp Med 1993; 177: 195-200.
13. Tillman DM, Harwood FG, Gibson AA, et al. Expression of genes that regulate Fas signalling and Fas-mediated apoptosis in colon carcinoma cells. Cell Death Differ 1998; 5: 450-7.
14. Kim DS, Kim MJ, Lee JY, et al. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features. Cancer 2007; 110: 2785-92.
15. Fleisher AS, Esteller M, Wang S, et al. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res 1999; 59: 1090-5.
16. Kang GH, Shim YH, Ro JY. Correlation of methylation of the hMLH1 promoter with lack of expression of hMLH1 in sporadic gastric carcinomas with replication error. Lab Invest 1999; 79: 903-9.
17. Moynahan ME, Chiu JW, Roller BH, et al. Brca1 controls homology-directed DNA repair. Mol Cell 1999; 4: 511-8.
18. Bean GR, Ibarra Drendall C, Goldenberg VK, et al. Hypermethylation of the breast cancer-associated gene 1 promoter does not predict cytologic atypia or correlate with surrogate end points of breast cancer risk. Cancer Epidemiol Biomarkers Prev 2007; 16: 50-6.
19. Ambudkar SV, Kimchi-Sarfaty C, Sauna ZE, et al. P-glycoprotein: from genomics to mechanism. Oncogene 2003; 22: 7468-85.
20. Lee WH, Morton RA, Epstein JI, et al. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 1994; 91: 11733-7.
21. Esteller M, Corn PG, Urena JM, et al. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res 1998; 58: 4515-8.
22. Melnikov AA, Gartenhaus RB, Levenson AS, et al. MSRE-PCR for analysis of gene-specific DNA methylation. Nucl Acids Res 2005; 33: 93-6.
23. Ueki T, Toyota M, Sohn T, et al. Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res 2000; 60: 1835-9.
24. Leung WK, Yu J, Ng EK, et al. Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues. Cancer 2001; 91: 2294-301.
25. Teitz T, Wei T, Valentine MB, et al. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 2000; 6: 529-35.
26. Gonzalez-Gomez P, Bello MJ, Inda MM, et al. Deletion and aberrant CpG island methylation of Caspase 8 gene in medulloblastoma. Oncol Rep 2004; 12: 663-6.
27. Ashley DM, Riffkin CD, Muscat AM, et al. Caspase 8 is absent or low in many ex vivo gliomas. Cancer 2005; 104: 1487-96.
28. Muhlethaler-Mottet A, Balmas K, Auderset K, et al. Restoration of TRAIL-induced apoptosis in a caspase-8-deficient neuroblastoma cell line by stable re-expression of caspase-8. Ann N Y Acad Sci 2003; 1010: 195-9.
29. Fulda S, Debatin KM. 5-Aza-2'-deoxycytidine and IFN-gamma cooperate to sensitize for TRAIL-induced apoptosis by upregulating caspase-8. Oncogene 2006; 25: 5125-33.
30. Wang L, Zhang F, Wu PP, et al. Disordered beta-catenin expression and E-cadherin/CDH 1 promoter methylation in gastric carcinoma. World J Gastroenterol 2006; 12: 4228-31.
31. Chan AO, Peng JZ, Lam SK, et al. Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut 2006; 55: 463-8.
32. Perri F, Cotugno R, Piepoli A, et al. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. pylori infected patients and effect of eradication. Am J Gastroenterol 2007; 102: 1361-71.
33. Enokida H, Shiina H, Igawa M, et al. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer. Cancer Res 2004; 64: 5956-62.
34. Qiu YY, Mirkin BL, Dwivedi RS. MDR1 hypermethylation contributes to the progression of neuroblastoma. Mol Cell Biochem 2007; 301: 131-5.
35. Van den Heuvel-Eibrink MM, Wiemer EA, de Boevere MJ, et al. MDR1 expression in poor-risk acute myeloid leukemia with partial or complete monosomy 7. Leukemia 2001;15:398-405.
36. Melki JR, Vincent PC, Clark SJ. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res 1999; 59: 3730-40.
37. Lubomierski N, Kersting M, Bert T, et al. Tumor suppressor genes in the 9p21 gene cluster are selective targets of inactivation in neuroendocrine gastroenteropancreatic tumors. Cancer Res 2001; 61: 5905-10.
38. Lee S, Hwang KS, Lee HJ, et al. Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia. Lab Invest 2004; 84: 884-93.
39. Krtolica K, Krajnovic M, Usaj-Knezevic S, et al. Come-thylation of p16 and MGMT genes in colorectal carcinoma: correlation with clinicopathological features and prognostic value. World J Gastroenterol 2007; 13: 1187-94.
40. Zheng S, Chen P, McMillan A, et al. Correlations of partial and extensive methylation at the p14(ARF) locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors. Carcinogenesis 2000; 21: 2057-64.
41. Kwabi-Addo B, Chung W, Shen L, et al. Age-related DNA methylation changes in normal human prostate tissues. Clin Cancer Res 2007; 13: 3796-802.
42. Marsit CJ, Houseman EA, Schned AR, et al. Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer. Carcinogenesis 2007; 28: 1745-51.